2,121
Views
7
CrossRef citations to date
0
Altmetric
Articles

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort

, , , ORCID Icon, , , , , , , , , & show all
Pages 805-814 | Received 30 Dec 2020, Accepted 10 Mar 2021, Published online: 26 May 2021

References

  • Mennemeyer R, Smith M. Multicystic, peritoneal mesothelioma: a report with electron microscopy of a case mimicking intra-abdominal cystic hygroma (lymphangioma). Cancer. 1979;44:692–698.
  • Noiret B, Renaud F, Piessen G, et al. Multicystic peritoneal mesothelioma: a systematic review of the literature. Pleura Peritoneum. 2019;4:20190024.
  • Zhang C-H, Yu J-W, Luo M. Multicystic peritoneal mesothelioma: a short review. Curr Probl Cancer. 2017;41:340–348.
  • Kusamura S, Kepenekian V, Villeneuve L, et al., PSOGI. Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2020;47:36–59.
  • Nizri E, Baratti D, Guaglio M, et al. Multicystic mesothelioma: operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy. Eur J Surg Oncol. 2018;44:1100–1104.
  • Baratti D, Kusamura S, Nonaka D, et al. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Ann Surg Oncol. 2007;14:2790–2797.
  • Baratti D, Vaira M, Kusamura S, et al. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Eur J Surg Oncol. 2010;36:1047–1053.
  • Wong WL, Johns TA, Herlihy WG, et al. Best cases from the AFIP: multicystic mesothelioma. Radiographics. 2004;24:247–250.
  • Jouvin I, Dohan A, Gergi P, et al. Intra-abdominal benign multicystic peritoneal mesothelioma. J Visc Surg. 2014;151:155–157.
  • Ross MJ, Welch WR, Scully RE. Multilocular peritoneal inclusion cysts (so-called cystic mesotheliomas). Cancer. 1989;64:1336–1346.
  • Weiss SW, Tavassoli FA. Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol. 1988;12:737–746.
  • Kurisu Y, Tsuji M, Shibayama Y, et al. Multicystic mesothelioma caused by endometriosis: 2 case reports and review of the literature. Int J Gynecol Pathol. 2011;30:163–166.
  • Safioleas MC, Constantinos K, Michael S, et al. Benign multicystic peritoneal mesothelioma: a case report and review of the literature. World J Gastroenterol. 2006;12:5739–5742.
  • Sawh RN, Malpica A, Deavers MT, et al. Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status. Hum Pathol. 2003;34:369–374.
  • Kannerstein M, Churg J. Peritoneal mesothelioma. Hum Pathol. 1977;8:83–94.
  • Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology. 1997;30:403–418.
  • van Ruth S, Bronkhorst MW, Van Coevorden F, et al. Peritoneal benign cystic mesothelioma: a case report and review of the literature. Eur J Surg Oncol. 2002;28:192–195.
  • Lee CE, Agrawal A. Remote recurrence of benign multicystic peritoneal mesothelioma. J Obstet Gynaecol Can. 2017;39:1042–1045.
  • DeStephano DB, Wesley JR, Heidelberger KP, et al. Primitive cystic hepatic neoplasm of infancy with mesothelial differentiation: report of a case. Pediatr Pathol. 1985;4:291–302.
  • González-Moreno S, Yan H, Alcorn KW, et al. Malignant transformation of “benign” cystic mesothelioma of the peritoneum. J Surg Oncol. 2002;79:243–251.
  • Sethna K, Mohamed F, Marchettini P, et al. Peritoneal cystic mesothelioma: a case series. Tumori J. 2003;89:31–35.
  • Mino JS, Monteiro R, Pigalarga R, et al. Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature. BMJ Case Rep. 2014;2014:bcr2013200212.
  • Chua TC, Yan TD, Deraco M, et al., Peritoneal Surface Oncology Group. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. Br J Surg. 2011;98:60–64.
  • Gilani SNS, Mehta A, García-Fadrique A, et al. Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival. Int J Hyperthermia. 2018;58:1–7.
  • Chicago Consensus Working Group. The Chicago consensus on peritoneal surface malignancies: management of peritoneal mesothelioma. Ann Surg Oncol. 2020;19:1–6.
  • Villeneuve L, Passot G, Glehen O, et al., RENAPE Network. The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry. Orphanet J Rare Dis. 2017;12:37–39.
  • Villeneuve L, Isaac S, Glehen O, et al. The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists. Ann Pathol. 2014;34:4–8.
  • Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–374.
  • Passot G, Bakrin N, Isaac S, et al. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol. 2014;40:957–962.
  • Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42.
  • Mercier F, Mohamed F, Cazauran J-B, et al. An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy. Int J Hyperthermia. 2019;36:744–752.
  • Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. [accessed 2020 May 19]. Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf
  • Vermersch S, Arnaud A, Orbach D, et al. Multicystic and diffuse malignant peritoneal mesothelioma in children. Pediatr Blood Cancer. 2020;67:571.
  • Cashin PH, Jansson Palmer G, Asplund D, et al. Peritoneal mesothelioma in Sweden: a population-based study. Cancer Med. 2019;8:6468–6475.
  • Low RN, Barone RM, Rousset P. Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: history, clinical applications, and implementation. Eur J Surg Oncol. 2019;47:65–74.
  • Ricci F, Borzellino G, Ghimenton C, et al. Benign cystic mesothelioma in a male patient: surgical treatment by the laparoscopic route. Surg Laparosc Endosc. 1995;5:157–160.
  • Esquivel J, Averbach A. Combined laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal mesothelioma. J Laparoendosc Adv Surg Tech A. 2009;19:505–507.
  • Mercier F, Jeremie G, Alyami M, et al. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma. Surg Endosc. 2020;34:4916–4918.
  • Rodríguez-Ortiz L, Arjona-Sánchez Á, Ibañez-Rubio M, et al. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. World J Surg. 2018;42:3120–3128.
  • Passot G, Dumont F, Goéré D, et al., BIG-RENAPE Surgery Working Group. Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE). Br J Surg. 2018;105:663–667.
  • Ortega-Deballon P, Glehen O, Levine E, et al. Childbearing after hyperthermic intraperitoneal chemotherapy: results from an international survey. Ann Surg Oncol. 2011;18:2297–2301.
  • van Bijsterveldt C, Willemsen W, Bulten J. Peritoneal benign mesothelioma during and after two pregnancies. Eur J Obstet Gynecol Reprod Biol. 2006;127:265–266.
  • Haase E, Yoo D, Sugarbaker PH. Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy. World J Surg Oncol. 2009;7:48.
  • Sheehan LA, Mehta AM, Sawan S, et al. Preserving fertility in pseudomyxoma peritonei, a novel approach. Pleura Peritoneum. 2017;2:33–36.
  • Evers DJ, Verwaal VJ. Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin. Br J Surg. 2011;98:287–292.
  • Huang Y, Alzahrani NA, Liauw W, et al. Effects of sex hormones on survival of peritoneal mesothelioma. World J Surg Oncol. 2015;13:210.
  • Kyser K, Bidus MA, Rodriguez M, et al. Spontaneous pregnancy following cytoreduction with peritonectomy and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol. 2006;100:198–200.